“Elevated #T2DM incidence after #COVID19 is greater, and persists longer, in hospitalised than non-hospitalised people. It is markedly less apparent post-#vaccination. Testing for T2DM after severe COVID-19 and promotion of vaccination are important tools in addressing this public health problem.” https://mstdn.social/@erictopol/110867212841430006

Pleased to host Prof Jason Kim @UMassDiabetes, an internationally renowned scientist in the field of #type2diabetes & #obesity, at the Institute today. Thanks for coming to #Melbourne & sharing your work on #inflammtion, #T2DM, #maternalhealth & #fattyliverdisease. @briandrew101 https://t.co/IAzkpIbdCi

Whether diabetes can be reversed is a hot topic, with lots of people refusing to even consider the possibility. Next week, at the DUKPC conference, the DiRECT team will announce that for 11 participants in their study out of the 48 that went into remission, remission has continued for 3 more years (total: 5).
#diabetes #t2diabetes #t2dm #type2

Whether doabetes can be reversed is a hot topic, with lots of people refusing to even consider the possibility. Next week, at the DUKPC conference, the DiRECT team will announce that for 11 participants in their study out of the 48 that went into remission, remission has continued for 3 more years (total: 5).
#diabetes #t2diabetes #t2dm #type2

Whether doabetes can be reversed is a hot topic, with lost of people refusing to even consider the possibility. Next week, at the DUKPC conference, the DiRECT team will announce that for 11 participants in their study out of the 48 that went into remission, remission has continued for 3 more years (total: 5).
#diabetes #t2diabetes #t2dm #type2

#CardioMastodon #Glucagonlikepeptide 1 receptor agonists (GLP1-RA) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) were individually proven to reduce major adverse cardiovascular events (MACE) in #T2DM patients, but the relative magnitude of benefits from these two drug classes is debated.
📌https://pubmed.ncbi.nlm.nih.gov/35195376/
📌 https://www.nmcd-journal.com/article/S0939-4753(12)00122-6/fulltext

I'm so sweet, I know. No, wait, that's the diabetes. #insulin #t2dm #humalog

Have you heard about exerkines? Me neither before last minute altough I’m an exercise scientist

:thinkerguns: But, exerkines describe the circulating factors produced and secreted by any tissue or organ that are released in response to repeated bouts of exercise.

And, importantly, exercise training represents an anti-inflammatory therapy and metabolism-improving strategy with minimal side effects for patients with #T2DM.

#Health #Exercise #SciComm

https://doi.org/10.1016/j.jshs.2022.11.003